Medicine and Dentistry
Glioblastoma
100%
Neuro-Oncology
78%
Neoplasm
36%
Surgery
33%
Ganglioglioma
32%
Overall Survival
26%
Tumor Treating Fields
25%
Aminolevulinic Acid
25%
Recurrent Disease
25%
Personalized Medicine
25%
Cancer Staging
25%
Cohort Effect
25%
Targeted Therapy
25%
Symptom
25%
Chemoradiotherapy
23%
Malignant Neoplasm
22%
Clinical Trial
17%
Cytoreductive Surgery
16%
Progression Free Survival
12%
Arm
12%
Cancer Therapy
9%
Porphyrin
8%
Precursor
8%
Adverse Event
8%
Household
7%
Patient Registration
7%
Medical Record
7%
Prostate Cancer
6%
Tumor Biopsy
6%
Lung Cancer
6%
Biological Marker
6%
Molecular Profiling
6%
Risk Reduction
5%
Prognostic Factor
5%
Cognition
5%
Biopsy
5%
Keyphrases
Fluorescence-guided Surgery
25%
Socioeconomic Variation
25%
Late-stage Cancer
25%
Neuro-oncology
25%
New Treatment Options
25%
5-Aminolevulinic Acid (5-ALA)
25%
Malignant Glioma
25%
Molecular Tumor Board
18%
Cytoreductive Surgery
16%
Glioma Grading
15%
Focal Deficit
10%
Tumor Response Assessment
8%
Class Ib
8%
Guided Surgery
8%
Red Fluorescence
8%
Progression-free Survival
8%
Radiochemotherapy
8%
End-stage Cancer
6%
Druggability
6%
Grade IV Glioma
5%
Grade I Glioma
5%
WHO Grade I
5%
Cognitive Change
5%
WHO Grade II Glioma
5%
WHO Grade IV
5%
Tumor Diameter
5%
Multifocality
5%
Partial Resection
5%
Gross Total Resection
5%
Postsurgical Treatment
5%
Nationwide Population
5%